Meetings

Development of a Pharmacokinetic Model of Mitotane: Towards Personalized Dosing in Adrenocortical Carcinoma
Thomas Kerkhofs, Luc Derijks, Hester Ettaieb, Jan Den Hartigh, Kees Neef, Hans Gelderblom, Henk-Jan Guchelaar and Harm Haak

Adrenal Incidentaloma: A Study of 65 Patients
Olga Martínez Colete and Ivette Pereira Venereo

Evaluation of Adrenal Incidentaloma
Anh Truong, Diane Mary Biskobing and Amelia Grover

The Impact of Repeated Cytoreduction in Combination with Maximal Medical Therapy on Clinical Outcomes and Quality of Life in Advanced Adrenal Cortical Carcinoma
Anand Vaidya, Rene Baudrand, Linda Wiinberg, Daniel T Ruan, Paul Shyn, Robert G Dluhy, Rana McKay, Toni Choueiri and Aymen Elfiky

The Functional Assessment and Growth Rates of Adrenal Incidentalomas: A Single Center Experience
Yuksel Altuntas, Suna Avci, Sayid Shafi Zuhur and Feyza Yener Ozturk

Pros and Cons of Dheas Testing for Adrenal Incidentaloma Workup
Serkan Yener, Hamiyet Yilmaz, Abdurrahman Comlekci and Tevfik Demir

Adrenocortical Carcinoma: What's Our Experience in the Past 25 Years?
Joana Menezes Nunes, Elisabete Rodrigues, Elisabete Rios, Catarina Eloy, Isabel Carvalho and Davide Carvalho

Adrenal Incidentalomas: From Diagnosis to Follow up
Joana Menezes Nunes, Elisabete Rodrigues, César Esteves, Rui Cunha Guimarães, Davide Carvalho and Isabel Ramos

Malignant Adrenal Incidentaloma - Is It a Tumor of Old People? a Clinical Analysis of a Group of 2666 Patients Observed at a Single Endocrinological Unit
Anna Kasperlik-Załuska, Andrzej Cichocki, Maciej Otto, Katarzyna Roszkowska, Rafal Z Slapa, Jadwiga Slowinska-Srzednicka, Elzbieta Roslonowska, Wojciech Jeske, Piotr Zdunowski and Wojciech Zgliczynski

Maximum Standardized Uptake Value: To Distinguish Between Benign and Malignant Adrenal Mass
Mehmet Calan, Mine Sencan Eren, Serkan Yener, Ozhan Ozdogan, Dilek Cimrin, Ali Riza Sisman, Mustafa Secil, Hatice Durak and Abdurrahman Comlekci

Adrenocortical Carcinoma: Retrospective Analysis of a Portuguese Cancer Centre
Joana Simoes-Pereira, Daniel Macedo, Margarida Silva-Vieira, Helena Vilar, Maria Conceição Pereira, Valeriano Leite and Maria João Bugalho

Quantitative Assessment By Computerized Morphometry of Ki-67 and Intratumoral Inflammatory Infiltrate in Benign and Malignant Adrenocortical Tumors
Paolo Dalino Ciaramella, Maurizio Vertemati, Duccio Petrella, Erika Grossrubatscher, Benedetta Zampetti, Marco Boniardi, Raffaele Pugliese and Paola Loli

Radiographic Characteristics of Incidentalomas in Patients Later Diagnosed with Adrenocortical Cancer
Thiago Machado Nogueira, Roy Lirov, Antonio M Lerario, Gary D Hammer, Maria Candida B V Fragoso, Elaine M Caoili and Tobias Else

ATR-101 Phase 1 Clinical Study for Adrenocortical Carcinoma
Aung Naing, Mouhammed Amir Habra, Rashmi Chugh, Marian Ijzerman, Martin D Phillips and David C Smith

Subclinical Hypercortisolemia in Bilateral Adrenal Incidentalomas - Who Should be Operated?
Lucyna Papierska, Jaroslaw B Cwikla, Michal Rabijewski, Piotr Glinicki, Maciej Otto and Anna A Kasperlik-Zaluska

Clinical Features of Incidentally Detected Adrenal Mass in Cancer Patients
Eun Ky Kim, Ji Hyun Lee, Eun Roh, Jae Hyun Bae, Jung Hee Kim, Ji Won Yoon, Seong Yeon Kim and Sang Wan Kim

Epicardial Fat Thickness and Left Ventricular Mass in Subjects with Adrenal Incidentaloma
Narin Nasiroglu Imga, Ozgul Ucar Elalmis, Mazhar Muslum Tuna, Bercem Aycicek Dogan, Deniz Sahin, Dilek Berker and Serdar Guler

Adherence to the Diagnostic Protocol for Adrenal Incidentalomas By Urologists
Maria Antonenko, Natalya Volkova, Serguey Dimitriadi, Ilia Davidenko, Igor Reshetnikov and Irina Dzherieva

The Specific p.R337H TP53 Germline Mutation in Adults with Adrenocortical Carcinoma
Christiane Gruetzmacher, Marilena Nakaguma, Mirela Costa de Miranda, Livia Mara Mermejo, Margaret Castro, Gabriela Resende, Antonio M Lerario, Berenice B Mendonca, Ana Claudia Latronico, Sonir Roberto Antonini, Madson Q. Almeida and Maria Candida B V Fragoso

The Combination of Insulin-like Growth-Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane As a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: A Multi-Institutional NCI-Sponsored Phase II Study
Antonio M Lerario, Francis P Worden, Carole Andrea Ramm, Elizabeth A Hasseltine, Walter M Stadler, Manisha H Shah, Edem Agamah, Krishna Rao and Gary D Hammer